Abstract
Purpose
Patients with lung cancer in Japan often receive aggressive care near the end of life and die in an acute care hospital. We describe the differences in end-of-life care for metastatic non-small-cell lung cancer (NSCLC) patients between general wards and a palliative care unit (PCU).
Methods
A retrospective analysis was conducted using data from patients who received at least second-line chemotherapy between 2002 and 2007 in a single institute. Among 72 eligible patients, we categorised patients into two groups, those who died in general wards (n = 57) and those who died in the PCU (n = 15), and examined end-of-life care including chemotherapy, do-not-resuscitate (DNR) decision making and treatment in the last 48 h of life.
Results
Mean number of days between the last chemotherapy and death was shorter in general wards than in the PCU (P = 0.019). Furthermore, 25% of patients in general wards received chemotherapy within the last 2 weeks of life. Rates of multiple hospitalisations in the last month of life appeared higher in general wards than in the PCU. Mean number of days between documentation of DNR and death was shorter in general wards than in the PCU (P = 0.0010). Patients in general wards received a greater volume of hydration than those in the PCU (P < 0.001).
Conclusions
Patients with metastatic NSCLC in general wards receive inappropriate care near the end of life. Further studies are needed to develop interventions for making decisions regarding end-of-life care.
References
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300
The SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously III hospitalised patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274:1591–1598
Toscani F, Di Giulio P, Brunelli C, Miccinesi G, Laquintana D (2005) How people die in hospital general wards: a descriptive study. J Pain Symptom Manage 30:33–40
Solloway M, Lafrance S, Bakitas M, Gerken M (2005) A chart review of seven hundred eighty-two deaths in hospitals, nursing homes, and hospice/home care. J Palliat Med 8:789–796
Paice JA, Muir JC, Shott S (2004) Palliative care at the end of life: comparing quality in diverse settings. Am J Hosp Palliat Care 21:19–27
Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133–1138
Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860–3866
Tang ST, Wu SC, Hung YN, Huang EW, Chen JS, Liu TW (2009) Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Ann Oncol 20:343–348
Sato K, Miyashita M, Morita T, Sanjo M, Shima Y, Uchitomi Y (2008) Quality of end-of-life treatment for cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: a retrospective chart review. Support Care Cancer 16:113–122
Degner LF, Sloan JA (1995) Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 10:423–431
Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742
Murillo JR Jr, Koeller J (2006) Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 11:1095–1099
Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF et al (2008) Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 113:826–833
Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K (2007) Comparing hospice and non-hospice patient survival among patients who die within a 3-year window. J Pain Symptom Manage 33:238–246
Harrington SE, Smith TJ (2008) The role of chemotherapy at the end of life: “when is enough, enough”? JAMA 299:2667–2678
Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 28:1203–1208
Zhang B, Wright AA, Huskamp HA, Nilsson ME, Maciejewski ML, Earle CC et al (2009) Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 169:480–488
Jonsson PV, McNamee M, Campion EW (1988) The “do-not-resuscitate” order. A profile of its changing use. Arch Intern Med 148:2373–2375
Gleeson K, Wise S (1990) The do-not-resuscitate order. Still too little, too late. Arch Intern Med 150:1057–1060
Berlowitz DR, Wilking SV, Moskowitz MA (1991) Do-not-resuscitate orders at a chronic care hospital. J Am Geriatr Soc 39:472–476
Ruhnke GW, Wilson SR, Akamatsu T, Kinoue T, Takashima Y, Goldstein MK et al (2000) Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest 118:1172–1182
Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A et al (2005) Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 16:640–647
Yamagishi A, Morita T, Miyashita M, Akizuki N, Kizawa Y, Shirahige Y et al (2008) Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care 25:412–418
Conflicts of interest statement
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakano, K., Yoshida, T., Furutama, J. et al. Quality of end-of-life care for patients with metastatic non-small-cell lung cancer in general wards and palliative care units in Japan. Support Care Cancer 20, 883–888 (2012). https://doi.org/10.1007/s00520-011-1374-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1374-7